ILDONG HOLDINGS CO.,LTD  Logo

ILDONG HOLDINGS CO.,LTD

000230 | KO

Overview

Corporate Details

ISIN(s):
KR7000230003
LEI:
Country:
South Korea
Address:
서울특별시 서초구 바우뫼로27길 2 일동제약빌딩, 서울특별시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

No description available.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-11 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 129.0 KB
2025-09-11 00:00
Major Shareholding Notification
최대주주등소유주식변동신고서
Korean 44.3 KB
2025-08-26 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 128.8 KB
2025-08-14 00:00
Interim / Quarterly Report
반기보고서 (2025.06)
Korean 2.1 MB
2025-07-30 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 16.3 KB
2025-07-30 00:00
M&A Activity
[기재정정]타법인주식및출자증권처분결정
Korean 21.5 KB
2025-07-30 00:00
Related Party Transaction
타법인주식및출자증권처분결정
Korean 15.8 KB
2025-07-28 00:00
Report Publication Announcement
결산실적공시예고(안내공시)
Korean 4.1 KB
2025-07-08 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 136.0 KB
2025-07-08 00:00
Major Shareholding Notification
최대주주등소유주식변동신고서
Korean 50.2 KB
2025-06-23 00:00
Related Party Transaction
타법인주식및출자증권처분결정
Korean 17.1 KB
2025-05-30 00:00
Governance Information
기업지배구조보고서공시
Korean 1015.5 KB
2025-05-27 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 128.8 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.9 MB
2025-05-12 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 16.3 KB

Automate Your Workflow. Get a real-time feed of all ILDONG HOLDINGS CO.,LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ILDONG HOLDINGS CO.,LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ILDONG HOLDINGS CO.,LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Develops approved cannabinoid medicines for pain, epilepsy, and heart failure.
United Kingdom
ANAN
Develops qPCR diagnostic kits and robotic automation systems for clinical and research laboratories.
Türkiye
ANGEN
ANAVEX LIFE SCIENCES CORP. Logo
Developing precision therapeutics for neurodegenerative and CNS disorders.
United States of America
AVXL
Anbio Biotechnology Logo
Develops and supplies in vitro diagnostic solutions for human and veterinary markets.
United States of America
NNNN
Anebulo Pharmaceuticals, Inc. Logo
Clinical-stage biotech developing an antidote for acute cannabinoid intoxication in ER patients.
United States of America
ANEB
AnGes, Inc. Logo
Develops gene-based medicines like HGF gene therapy, DNA vaccines, and NF-kB decoys.
Japan
4563
Anika Therapeutics, Inc. Logo
Develops joint preservation and regenerative solutions for early intervention orthopedic care.
United States of America
ANIK
ANIMALCARE GROUP PLC Logo
Develops & sells veterinary prescription & OTC medicines for professionals worldwide.
United Kingdom
ANCR
ANI PHARMACEUTICALS INC Logo
Develops, manufactures, and markets branded/generic drugs and OTCs for niche therapeutic areas.
United States of America
ANIP
Annexin Pharmaceuticals AB Logo
Developing Annexin A5 protein to treat vascular, inflammatory, and cancerous diseases.
Sweden
ANNX

Talk to a Data Expert

Have a question? We'll get back to you promptly.